Just got my Medicines offer...

Anonymous

Guest
And it was a good one. Can't wait to send over my resignation to my manager.

Just when I was giving up hope... out of the sky falls The Medicines Company and a big-time offer. They actually had me name my offer. Then they signed off on it. No BS. I'm still trying to wrap my mind around what just happened!

Adios, amigos!

PS My top 3 infusion suites are ready to make the switch. aka, Relationship selling, bitches!
 






And it was a good one. Can't wait to send over my resignation to my manager.

Just when I was giving up hope... out of the sky falls The Medicines Company and a big-time offer. They actually had me name my offer. Then they signed off on it. No BS. I'm still trying to wrap my mind around what just happened!

Adios, amigos!

PS My top 3 infusion suites are ready to make the switch. aka, Relationship selling, bitches!

Please know all of you looking at this post, that while this person may have gotten a job and offer for Medicines company, they did not name their offer.
 






And it was a good one. Can't wait to send over my resignation to my manager.

Just when I was giving up hope... out of the sky falls The Medicines Company and a big-time offer. They actually had me name my offer. Then they signed off on it. No BS. I'm still trying to wrap my mind around what just happened!

Adios, amigos!

PS My top 3 infusion suites are ready to make the switch. aka, Relationship selling, bitches!

No infusion center will touch this dog. here's why:

1) You and your customer have no idea on cost or reimbursement yet

2) Contraindications - Use of intravenous unfractionated heparin sodium is contraindicated for 48 hours after ORBACTIV™ administration because the activated partial thromboplastin time (aPTT) test results are expected to remain falsely elevated for approximately 48 hours after ORBACTIV administration.

3) Warnings and Precautions - Concomitant warfarin use: Co-administration of ORBACTIV and warfarin may result in higher exposure of warfarin, which may increase the risk of bleeding. Use ORBACTIV in patients on chronic warfarin therapy only when the benefits can be expected to outweigh the risk of bleeding.

Coagulation test interference: ORBACTIV has been shown to artificially prolong aPTT for up to 48 hours, and may prolong PT and INR for up to 24 hours.

Hypersensitivity reactions have been reported with the use of antibacterial agents including ORBACTIV. Discontinue infusion if signs of acute hypersensitivity occur. Monitor closely patients with known hypersensitivity to glycopeptides.

Infusion-related reactions have been reported. Slow the rate or interrupt infusion if infusion reaction develops.

Osteomyelitis: Institute appropriate alternate antibacterial therapy in patients with confirmed or suspected osteomyelitis.

4) 3 hour infusion means the patient will be at the office for 4 hours and tying-up chair time and staff time. Will they get reimbused for all this chair time?

You should have gone to Durata because it's not even close between the two drugs. Dalba is 30 minutes with none of the serious safety concerns and likely a single dose indication on the way. Plus new indications down the road for things orita will never get.

Your relationship with them is over.
 












No infusion center will touch this dog. here's why:

1) You and your customer have no idea on cost or reimbursement yet

2) Contraindications - Use of intravenous unfractionated heparin sodium is contraindicated for 48 hours after ORBACTIV™ administration because the activated partial thromboplastin time (aPTT) test results are expected to remain falsely elevated for approximately 48 hours after ORBACTIV administration.

3) Warnings and Precautions - Concomitant warfarin use: Co-administration of ORBACTIV and warfarin may result in higher exposure of warfarin, which may increase the risk of bleeding. Use ORBACTIV in patients on chronic warfarin therapy only when the benefits can be expected to outweigh the risk of bleeding.

Coagulation test interference: ORBACTIV has been shown to artificially prolong aPTT for up to 48 hours, and may prolong PT and INR for up to 24 hours.

Hypersensitivity reactions have been reported with the use of antibacterial agents including ORBACTIV. Discontinue infusion if signs of acute hypersensitivity occur. Monitor closely patients with known hypersensitivity to glycopeptides.

Infusion-related reactions have been reported. Slow the rate or interrupt infusion if infusion reaction develops.

Osteomyelitis: Institute appropriate alternate antibacterial therapy in patients with confirmed or suspected osteomyelitis.

4) 3 hour infusion means the patient will be at the office for 4 hours and tying-up chair time and staff time. Will they get reimbused for all this chair time?

You should have gone to Durata because it's not even close between the two drugs. Dalba is 30 minutes with none of the serious safety concerns and likely a single dose indication on the way. Plus new indications down the road for things orita will never get.

Your relationship with them is over.

Spot on!
 






No infusion center will touch this dog. here's why:

1) You and your customer have no idea on cost or reimbursement yet

2) Contraindications - Use of intravenous unfractionated heparin sodium is contraindicated for 48 hours after ORBACTIV™ administration because the activated partial thromboplastin time (aPTT) test results are expected to remain falsely elevated for approximately 48 hours after ORBACTIV administration.

3) Warnings and Precautions - Concomitant warfarin use: Co-administration of ORBACTIV and warfarin may result in higher exposure of warfarin, which may increase the risk of bleeding. Use ORBACTIV in patients on chronic warfarin therapy only when the benefits can be expected to outweigh the risk of bleeding.

Coagulation test interference: ORBACTIV has been shown to artificially prolong aPTT for up to 48 hours, and may prolong PT and INR for up to 24 hours.

Hypersensitivity reactions have been reported with the use of antibacterial agents including ORBACTIV. Discontinue infusion if signs of acute hypersensitivity occur. Monitor closely patients with known hypersensitivity to glycopeptides.

Infusion-related reactions have been reported. Slow the rate or interrupt infusion if infusion reaction develops.

Osteomyelitis: Institute appropriate alternate antibacterial therapy in patients with confirmed or suspected osteomyelitis.

4) 3 hour infusion means the patient will be at the office for 4 hours and tying-up chair time and staff time. Will they get reimbused for all this chair time?

You should have gone to Durata because it's not even close between the two drugs. Dalba is 30 minutes with none of the serious safety concerns and likely a single dose indication on the way. Plus new indications down the road for things orita will never get.

Your relationship with them is over.




Blah, blah, BLAH!

I can't hear you. I have a $155,000 *base salary* check stuck in my ears and my company car (SUV) is doing 80 on the freeway. I repeat... COMPANY. CAR.

Oh yeah... and stock options (5000 shares) plus RSUs, and no call reporting... and no jack@ss senior managers like you posting on cafepharma because you realize you are nothing more than smoke 'n mirrors.

PS my bonus plan is crazy stupid w La Medicinas. $$$$$$$$$$$$$$$$$$$$$$ Cha. Ching.
 


















This chart says it all - MDCO leadership has generated 0 shareholder value over the last 14 years. Imagine its the end of 2015 and there primary revenue product (angiomax) is now generic? Nothing but leftovers in there portfolio and pipeline. Layoffs, sales of assets, revisit those 5.00 per share days. The proof is in the history of its stock chart. Tells you objectively about the cometence of its leadership.

http://finance.yahoo.com/q/bc?s=MDCO&t=my&l=on&z=l&q=l&c=
 






You must not know much about their pipeline. Two gram negatives, and a short acting anti platelet. Perhaps you don't understand the value of that if you haven't sold in the cardiology market. Everything else is buffer. A little revenue is better than no revenue. Stock has taken a beating much like many other companies. In this industry everything is a risk. Cubist is not all roses either. Pick which works for you. The opportunity won't be for everyone.
 






No infusion center will touch this dog. here's why:

1) You and your customer have no idea on cost or reimbursement yet

2) Contraindications - Use of intravenous unfractionated heparin sodium is contraindicated for 48 hours after ORBACTIV™ administration because the activated partial thromboplastin time (aPTT) test results are expected to remain falsely elevated for approximately 48 hours after ORBACTIV administration.

3) Warnings and Precautions - Concomitant warfarin use: Co-administration of ORBACTIV and warfarin may result in higher exposure of warfarin, which may increase the risk of bleeding. Use ORBACTIV in patients on chronic warfarin therapy only when the benefits can be expected to outweigh the risk of bleeding.

Coagulation test interference: ORBACTIV has been shown to artificially prolong aPTT for up to 48 hours, and may prolong PT and INR for up to 24 hours.

Hypersensitivity reactions have been reported with the use of antibacterial agents including ORBACTIV. Discontinue infusion if signs of acute hypersensitivity occur. Monitor closely patients with known hypersensitivity to glycopeptides.

Infusion-related reactions have been reported. Slow the rate or interrupt infusion if infusion reaction develops.

Osteomyelitis: Institute appropriate alternate antibacterial therapy in patients with confirmed or suspected osteomyelitis.

4) 3 hour infusion means the patient will be at the office for 4 hours and tying-up chair time and staff time. Will they get reimbused for all this chair time?

You should have gone to Durata because it's not even close between the two drugs. Dalba is 30 minutes with none of the serious safety concerns and likely a single dose indication on the way. Plus new indications down the road for things orita will never get.

Your relationship with them is over.

Which is why Lilly ditched the drug.
 
























Amazing how you can spend no time at a company and have a view about its culture. I bet you have been jumping companies for most of your career. You have no idea what you are in for.
 






Has anyone actuall read the job description for medicine company and you think they are going to run their company like the wildwest? straight from their website:

Description
Summary



The Infectious Disease Care (SPC) Customer Solutions Manager (CSM) is the primary sales representative for MDCO and will be the point person managing all of the revenue generating activities for IDC products within a hospital. The person will be assigned a group of 9-11 hospitals with an estimated revenue potential of approximately $20mm. The CSM is expected to be the onsite clinical expert working closely with HCPs during initial and ongoing usage and is the person responsible for expanding usage as rapidly and possible. The person reports directly to an Engagement Partner (EP).



Key Performance Objectives



1.Performance management: successfully manage a broad portfolio of products over a group of assigned hospitals.
•Lead the effort to break silos and help hospitals rethink their business model from a customer point of view.
•Establish and achieve business performance measures for each hospital: revenue, customer satisfaction, clinical, and business outcomes.
•Develop formal and informal reporting and communication systems.
•Establish and meet the monthly and annual performance objectives for each hospital.
•Implement the 4D consultative sales process – Discover, Design, Develop, Deliver.
•Collaborate closely with SE, GHS, MAD and others to meet customer and plan needs.
2.Quickly acquire product, environmental and competitive knowledge, specifically:
•Build a foundation of clinical, business and hospital knowledge.
•Build and expand a key stakeholder and influencer network using all tools available.
•Understand existing IDC care pathways and map out the care pathways for each assigned hospital.
•Learn customer value propositions of our and our competitors’ solutions including supporting data.
•Research, evaluate and prioritize hospitals for early-adopters opportunities.
3.Discovery process: within 60-90 days lead the effort to build an account knowledge base for each hospital.
•Understand the hospital business model, challenges, structure, priorities and focus.
•Document critical pathways, people, patients, processes, decision-makers, financial and approval processes for all key departments.
•Build and map a 360° network of influencers.
4.Collaborate closely with the MDCO engagement team
•Become the clinical expert and primary driver of all hospital related activity.
•Learn, understand and follow all rules/regulations that deal with customer engagement including MDCO rules of engagement.
5.Planning process: build a comprehensive engagement plan for each hospital.
•Document the competitive landscape and key hurdles.
•Understand at the process and user level the clinical and business needs of each hospital.
•Identify the support and unmet needs of each hospital, business decision-makers and HCPs
6.Project management: act as a project manager (aka QB or PG) insuring the sales plan is implemented properly and successfully met.
•Act as an account manager tracking and monitoring performance. As part of this identify problems, opportunities, and challenges and assign and follow-up as appropriate.
•Collaborate, clarify and deploy resources to ensure critical tasks are identified and met.
•Work with MDCO team to prepare an evolving and flexible prioritized action plan.


7.Gain the necessary approvals leading the effort to prepare and implement a comprehensive 6-12 month sales plan for each assigned hospital. This needs to include:
•Act as point person to obtain formulary approval.
•Define monthly revenue goals for each hospital. Specifically: identify, quantify and prioritize opportunities within each hospital.
•Establish and validate the unique needs and challenges of each hospital, their processes, key stakeholders, business issues and internal politics.
•Go beyond the product. As needed provide introductory education to hospital: mission, strategy, tactics and implementation process.
8.Implement a rapid launch sales effort within each hospital.
•Working closely with early-adopters (HCPs) develop an approach to identify opportunities for initial usage.
•Support these efforts before, during and after first usage to the max possible to ensure successful outcomes.
•Develop critical tracking information. Convert early-adopters into advocates.
•Provide tools and support to demonstrate value.
9.Accelerate efforts to expand usage to meet monthly revenue objectives.
•Develop a means to scale and maintain maximum usage within each hospital.
•Identify and prioritize all potential opportunities.
•Successfully implement the plan working each opportunity and overcoming normal challenges.
•Identify key tracking and usage metrics. Monitor activities and provide appropriate feedback and control.
•Be in a position to take-over an existing account going through the expansion phase.
10.Initiate and manage on all business and contracting aspects for each hospital.
•Coordinate the formulary approval and related approval processes
•Collaborate with EP to negotiate complex agreements ensuring cost and revenue targets are met

note the use of document, track, validate, report,etc etc etc. Amazing how this is the only industry where sales people complain about processes that best in classs organizations deploy.
 






Yes for a 6 figure salary they actually expect you to work! I have friends that have worked there and believe me the culture is nothing like Cubist. High expectations but you are treated like an adult. If you have to practice how to detail you probably aren't a good fit. If you need the oversight of a manager in the field with you, you probably aren't a good fit. I'm staying put at Cubist but I get why others are interested. I support friends doing what's best for their families.
 












Break silos and get hospitals to rethink their business models? And where in Oz is this company located?

Good luck with all that. Better have tried and all have failed to break the pharmacy silo.
 






That would make sense if the company had proven leadership. There business model isnt sustainable.

And the sales leadership we've been given at Cubist is what exactly? A jerk who thinks intimidation is motivation? Talks down to you to your face regardless of what you've accomplished? Can't type an intelligent email to save his life, add can't be bothered to reply to any of yours because you're just a CBM? Yeah, definitely wouldn't want to leave that!

As for sustainable business model, nice job regurgitating someone else's comment. The drug has plenty of patent life left and from what I can tell, they pay you with real money. Lots of it. They also treat you like a human being and don't expect you to juggle 4 drugs while TC lobs dodgeballs at your crotch. Enjoy the bruises and your "proven leadership!"